Atlas Trials

A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

Clinical trial NCT00447954 · COMPLETED

Trial details

NCT number
NCT00447954
Sponsor
Neurotech Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
Start date
2007-01-05
Primary completion
2009-05-11
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.